September 23, 2016 , Boston, MA. Outcome Capital (outcomecapital.wpengine.com), an investment banking firm that serves middle-market growth companies in life sciences and technology markets, today announced it has moved its New England office to the heart of Boston, now operating at 99 High Street.
Led by experienced investment bankers and operations professionals, Outcome Capital provides merger and acquisition, private debt and equity placement and other strategic and corporate finance advisory services. The firm utilizes its proven approach to value enhancement by assisting boards and management teams in navigating both the financial and strategic markets and in implementing the best path for success.
“We are more than doubling our space to accommodate more employees as a component of our growth and expansion strategy,” said Dr. Oded Ben-Joseph, Managing Director at Outcome Capital. “We are excited to be more centrally located in the heart of a worldwide biotech hub, and the proximity to Cambridge will allow us to better serve our clients.”
About Outcome Capital
Outcome Capital is a unique investment banking firm that provides middle-market growth companies in the life sciences, healthcare services and technology markets with a value-added client-centric approach to merger, acquisition and corporate finance advisory services. The firm utilizes its proven approach to value enhancement by assisting boards and management teams in navigating both the financial and strategic markets and in implementing the best path for success. Outcome Capital’s strength stems from its unique ability to draw on its wide range of operational, strategic and private equity experience, its expertise across the value building life-cycle, and its broad industry relationships. The professionals at Outcome Capital take pride in their ability to help their clients to make well-informed strategic decisions and recognize the full value created by their vision. For more information, visit: outcomecapital.wpengine.com.
June 23, 2021, Reston, VA Outcome Capital, an investment banking firm that serves middle market growth companies in aerospace, defense and government services, technology, and life sciences, is pleased to announce that Nova Technologies (“Nova” or the “Company”) has received an equity investment from Slate Capital Group, a private equity firm based in Baltimore, MD, […]Read More
June 17, 2021 09:40 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–Outcome Capital, a specialized advisory and investment banking firm that serves middle market companies in the life science and technology segments, today announced that Veranex, a newly formed concept-to-commercialization service provider dedicated to the medtech industry, has acquired Boston Healthcare Associates (BHA), a global strategy consulting […]Read More
Outcome Capital Life Science Market Pulse August 2021 Click to view our LifeSciences Pulse NewsletterDownload